Skip to Main Content

Paper Details

Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases.
Mol Oncol
6
2022
-, 10-N-nonyl-Acridine, PDH, PDK, PDK1, PDK2, PDK3, PDK4, RNA, Tozasertib, aurora kinase, aurora kinase family, cancer, dichloroacetate, glioma, high-grade pediatric and adult glioma, high-grade pediatric and adult glioma cell lines, oxygen, pyruvate, pyruvate dehydrogenase, pyruvate dehydrogenase kinase isoenzyme 4, pyruvate dehydrogenase kinases, resistant cells, tozasertib
Author NameAffiliation
Dhivyaa RajasundaramUniversity of Pittsburgh School of Medicine
Sameer AgnihotriUniversity of Pittsburgh School of Medicine
Sameer AgnihotriUPMC Hillman Cancer Center
Ian F PollackUniversity of Pittsburgh School of Medicine
Ian F PollackUPMC Hillman Cancer Center
Ian F PollackUniversity of Pittsburgh School of Medicine
Ian F PollackUPMC Hillman Cancer Center
  • 1 - 7

Datasets

Release 1.2